Alcoholic Hepatitis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Key Companies – DURECT Corporation, Novartis, Intercept Pharmace

April 06 16:25 2023
Alcoholic Hepatitis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Key Companies - DURECT Corporation, Novartis, Intercept Pharmace
DelveInsight Business Research LLP
DelveInsight’s “Alcoholic Hepatitis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Alcoholic Hepatitis, historical and forecasted epidemiology as well as the Alcoholic Hepatitis market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

DelveInsight’s Alcoholic Hepatitis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Alcoholic Hepatitis, historical and forecasted epidemiology as well as the Alcoholic Hepatitis market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

The Alcoholic Hepatitis market report provides current treatment practices, emerging drugs, Alcoholic Hepatitis market share of the individual therapies, and current and forecasted Alcoholic Hepatitis market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Alcoholic Hepatitis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Alcoholic Hepatitis market.

Alcoholic Hepatitis Overview

Alcoholic hepatitis is inflammation of the liver caused by drinking alcohol. Alcoholic hepatitis is most likely to occur in people who drink heavily over many years. However, the relationship between drinking and alcoholic hepatitis is complex.

Excessive alcohol consumption could result in fatty liver disease or steatosis, alcoholic hepatitis (AH), and eventually cirrhosis. Alcoholic hepatitis is a severe syndrome of alcoholic liver disease (ALD), characterized by rapid onset of jaundice, malaise, tender hepatomegaly, and subtle features of systemic inflammatory response. The recent worsening profile and trends of patients with AH-related hospitalizations in the United States suggest its importance in the current realm of clinical practice with its subsequent management.

Alcoholic Hepatitis Epidemiology Insights

Approximately two-thirds of adults in the United States drink alcohol, while 7.2% suffer from alcohol use disorder (AUD). Excessive alcohol intake is the third leading preventable cause of death in the United States. A 10-year survey, from 2001 through 2011 from 211 hospitals revealed 0.08% to 0.09% admissions related to alcoholic hepatitis

Click here to learn more about the Alcoholic Hepatitis Market Landscape

The Report Covers the Alcoholic Hepatitis Epidemiology Segmented by:

  • Alcoholic Hepatitis incident cases 

  • Alcoholic Hepatitis prevelant cases 

  • Alcoholic Hepatitis diagnosed cases 

  • Alcoholic Hepatitis treatment cases 

  • Alcoholic Hepatitis onset-specific cases 

Alcoholic Hepatitis Market Outlook 

The Alcoholic Hepatitis market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Alcoholic Hepatitis market trends by analyzing the impact of current Alcoholic Hepatitis therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of the Alcoholic Hepatitis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Alcoholic Hepatitis market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Alcoholic Hepatitis market in 7MM is expected to witness a major change in the study period 2019-2032.

 

Key Companies Working in the Alcoholic Hepatitis Market

  • DURECT Corporation

  • Novartis

  • Intercept Pharmaceuticals 

  • Mallinckrodt 

And many others 

Alcoholic Hepatitis Therapies Covered and Analyzed in the Report:

  • DUR-928 30 mg

  • Selonsertib

  • Prednisolone

  • Canakinumab

And many others 

Learn more about the Key Companies and Emerging Therapies in the Alcoholic Hepatitis Market

Table of Contents 

  1. Key Insights 

  2. Alcoholic Hepatitis Introduction 

  3. Executive Summary of Alcoholic Hepatitis  

  4. Disease Background and Overview

  5. Epidemiology and patient population

  6. Alcoholic Hepatitis Emerging Therapies

  7. Alcoholic Hepatitis Market Outlook

  8. Market Access and Reimbursement of Therapies

  9. Market Drivers 

  10. Market Barriers 

  11. Appendix

  12. Report Methodology

  13. DelveInsight Capabilities

  14. Disclaimer

Learn about the detailed offerings of the report @ Alcoholic Hepatitis Market Outlook 

Related Reports 

Alcoholic Hepatitis Pipeline Insights

“Alcoholic Hepatitis – Pipeline Insight, 2023” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in the Alcoholic Hepatitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products by stage, route of administration, and molecule type. 

Trending Reports by DelveInsight

  • Adalimumab Biosimilar Market

  • Arbovirus Infection Market

  • Artificial Pancreas Device System Market

  • Dental Equipment Market

  • Gluten Sensitivity Market

  • Hypothyroidism Market

  • Inflammatory Bowel Disease Market

  • Mayus Kinase Jak Inhibitors Market

  • Mild Dry Eye Market

  • Mucopolysaccharidosis Market

  • Oncolytic Virus Cancer Therapy Market

  • Pyoderma Gangrenosum Market

  • Transdermal Drug Delivery Devices Market

  • Intrathecal Pumps Market

  • Hedgehog Pathway Inhibitors Market

  • Yellow Fever Market

  • Laryngeal Cancer Market

  • Female Infertility Market

  • Gender Dysphoria Market

  • Chronic Brain Damage Market

  • Spain Healthcare Outlook Market

  • Malignant Fibrous Histiocytoma Market

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services